MARKET

KURA

KURA

Kura Oncology Inc
NASDAQ
8.77
+0.10
+1.15%
After Hours: 8.70 -0.07 -0.80% 18:23 09/28 EDT
OPEN
8.68
PREV CLOSE
8.67
HIGH
8.85
LOW
8.60
VOLUME
384.77K
TURNOVER
0
52 WEEK HIGH
17.27
52 WEEK LOW
8.34
MARKET CAP
651.05M
P/E (TTM)
-4.2780
1D
5D
1M
3M
1Y
5Y
Analysts Are Bullish on These Healthcare Stocks: Virpax Pharmaceuticals (VRPX), Kura Oncology (KURA)
TipRanks · 1d ago
Curaleaf CIO, Camilo Lyon Says 'Brand Also Entails Customer Experience, Says Brands Matter To Consumers'
Benzinga · 1d ago
Kura: Preclinical Data Shows Potential Of KO-2806 To Enhance Antitumor Activity Of KRAS Inhibitors
NASDAQ · 1d ago
Promising Outlook for Kura Oncology: An Analysis of its Potential Success Factors and Strategic Focus
TipRanks · 1d ago
Kura Oncology Enters Oversold Territory (KURA)
NASDAQ · 4d ago
Weekly Report: what happened at KURA last week (0918-0922)?
Weekly Report · 4d ago
Kura's Ziftomenib: The Swiss Army Knife In AML Therapy
Seeking Alpha · 4d ago
Kura Oncology Inc: Statement of acquisition of beneficial ownership by individuals
Press release · 09/21 21:06
More
About KURA
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of medicines for the treatment of cancer. The Company’s pipeline consists of small molecule product candidates that target cancer signaling pathways. The Company’s products candidate includes Ziftomenib, Tipifarnib, and KO-2806. The Ziftomenib is a potent, selective, reversible and oral small molecule inhibitor that blocks the interaction of two proteins, menin and the protein expressed by the Lysine K-specific Methyl Transferase 2A gene for the treatment of genetically defined acute myeloid leukemia (AML) patients. Tipifarnib is a potent, selective and orally bioavailable inhibitor of farnesyl transferase. KO-2806, is a next generation farnesyl transferase inhibitor (FTI), which it demonstrates improved potency, pharmacokinetic and physicochemical properties relative to earlier FTI drug candidates.

Webull offers kinds of Kura Oncology Inc stock information, including NASDAQ:KURA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KURA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading KURA stock methods without spending real money on the virtual paper trading platform.